The ICE-T Congress is dedicated to fostering a strong and enduring Academic-Community partnership, one designed to cultivate mutual learning, provide meaningful support, and remove barriers to care while encouraging bold aspirations.
This initiative commenced in Kansas City, Kansas, in July 2024. Building upon that foundation, the first National ICE-T Congress was successfully convened in Orlando, Florida, in July 2025. Following this milestone, preparations are now underway for the second regional ICE-T Congress, scheduled to take place in Kansas City, Kansas, in September 2025. The mission of the ICE-T Congress extends beyond regional and national boundaries. Advocacy efforts are being advanced at every level, including internationally, with plans for a forthcoming congress outside the United States.
At its core, the ICE-T Congress is committed to representing and supporting every patient who has encountered obstacles in their pursuit of healing. By championing equitable access to ICE-T therapies, the initiative endeavors to inspire systemic change and bring renewed hope to individuals and communities most in need.
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared some key highlights from ICE-T Congress:
“Introduction to Cellular Therapies: Real-World Applications, Real-Time Learning” Presented by Dr. Joseph McGuirk at the Annual Ice-T Conference.”
Dr. Bilal Abid on Clinical Trials and BiTEs:
“Dr. Bilal Abid presents on Clinical Trials and BiTEs access in the community – expanding innovative therapies beyond major centers and closer to patients.”
Dr. Roy Jensen on Building a World-Class Center:
“The Future Starts Here: Dr. Roy Jensen on Designing a World-Class Cancer Center.”
Access to CAR-T and BiTEs – bringing therapies closer to patients:
“A dynamic panel led by Zahra Mahmoudjafari on Access to CAR-T and BiTEs featuring Dr. McGuirk, Dr. Bilal Abid, Dr. Mattar and Dr. Kambhampati – tackling how to bring cutting-edge therapies closer to patients!”
Myeloma Session – Dr. Jeries Kort on Advances in BiTEs:
“Now presenting in the Myeloma Session: Dr. Jeries Kort on “Advances in BiTEs for Myeloma” – highlighting the latest innovations bringing new hope to patients!”
CAR-T and BiTEs in Myeloma – panel moderated by Dr. Jeries Kort:
“Panel Discussion on Access to CAR-T and BiTEs in Myeloma – moderated by Dr. Jeries Kort with panelists Drs. Atrash, Mewawalla, Lutfi and Palmer. Expanding hope, breaking barriers.”
“Big thanks to Dr. Jeries Kort and our expert panelists Drs. Atrash, Mewawalla, Diab, Lutfi, and Palmer for today’s engaging discussion on access to CAR-T and bispecifics at ICE-T 2025.”
Panel on AEs and Management of BCMA/GPRC5D BiTEs and CAR-T:
“Panel Discussion led by Jordan Snyder, PharmD with Drs. Kort, Mewawalla, Diab and Mattar on AEs of BCMA and GPRC5D BiTEs/CAR-T and managing patients on BiTEs.”
Side effects, GPRC5D bispecifics, CAR-T, and patient management:
“Side effects, GPRC5D bispecifics, CAR-T, and patient management – all tackled in today’s panel led by Jordan Snyder with experts Kort, Mewawalla, Diab, Mattar, and Singh at ICE-T 2025.”
Dr. Steven Soper at ICE-T 2025:
“From bench to bedside – Dr. Steven Soper walked us through cutting-edge CAR-T research at ICE-T 2025, showing how translational science is driving the next breakthroughs.”
“Panel Discussion now with Drs. McGuirk, Graff, Bilal Abid and Mattar joined by Zahra Mahmoudjafari and Stephani Nigro, MSN, RN – sharing expertise on advancing cellular therapies”
The Era of Immune Antibody Therapies in Lung Cancer:
“Beyond Hematology! Dr. Chao H. Huang, Director of Thoracic Oncology KU Cancer Center, presents “The Era of Immune-Based Antibody Therapies in Lung Cancer” – pushing the boundaries of innovation in thoracic oncology.”
“Panel on Solid Tumors and Autoimmune moderated by Dr. TJ Schieber with experts Drs. Raed Al-Rajabi, Chao Huang, Kimberly Liang and Kelly Liang – advancing therapies and patient care across oncology and autoimmune diseases.”
“Winners of the USMIRC Medals USMIRC Medal 2025 (Royal Award): Zahra Mahmoudjafari PharmD/Nausheen Ahmed, MD.”
“USMIRC Medal 2025 (Eagle Award): Prerna Mevawalla, MD.”
“USMIRC Medal 2025 (Mikael-Rayann Foundation Award): Kashif Amin, MD.”
“On behalf of the ICE-T Congress directors, we’re proud to donate to the new Cancer Building at KUMC and to patient assistance – giving back to our community and building the future together.”
